Dillard's, Inc.
NYSE:DDSDepartment Stores
+$7.73 today
- Market cap
- $7.62B
- Beta
- 1.17
- P/E (TTM)
- 13.3
- EPS (TTM)
- $42.14
- Dividend yield
- 5.57%
Volume 0.13M
Average 0.11M
DDS Capital Expenditures
Cash spent on property, plant, equipment, and other long-term assets.
Dillard's, Inc.NYSE: DDS
Capital Expenditures · Q2 FY2026 · quarter ended Aug 2026
Capital expenditures dips below year-ago levels
Q2 FY2026 capital expenditures of $22.3M (cash outflow) fell 16.4% year over year, behind the +2.7% change in trailing-twelve-month capital expenditures. Sequentially, it rose 29.7% from the prior quarter. Over 3 fiscal years it compounded at -8.0% a year.
Context
- Capital expenditures amounted to 1.4% of revenue in FY2025, down 0.2 pp from a year earlier.
- Capital expenditures grew in size in 1 of the last 3 fiscal years.
- FY2025 was the smallest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -16.4% toward the trailing-twelve-month pace of +2.7%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Capital Expenditures history
USD · from the cash flow
- Latest · FY2025
- (93.4M) USD
- Year-over-year change
- +10.7%
| Period | Period end | Capital Expenditures | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-31 | (93.4M) | +10.7% |
| FY2024 | 2025-02-01 | (104.55M) | +21.4% |
| FY2023 | 2024-02-03 | (132.94M) | -10.7% |
| FY2022 | 2023-01-28 | (120.11M) | -15.1% |
| FY2021 | 2022-01-29 | (104.36M) | — |
Capital Expenditures vs competitors
How DDS compares with its peers on the latest reported figures
- Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +2.7% is the 4th highest of 10, against a peer median of -4.3%.
- Capital expenditures amounts to 1.4% of revenue for DDS, versus a peer median of 3.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.3B USD | +33.4% | +22.3% | 32.5% | |
| LTM Aug 2026 | $724M USD | +62.3% | -11.8% | 4.7% | |
| LTM Jun 2026 | $483M USD | -2.2% | -10.9% | 3.4% | |
| LTM Jun 2026 | $404M USD | -19.5% | -9.0% | 3.6% | |
| LTM Aug 2026 | $209M USD | -11.4% | -6.1% | 3.1% | |
| LTM Aug 2026 | $204.23M USD | -4.3% | -11.5% | 3.8% | |
| LTM Jun 2026 | $100.82M USD | -19.4% | -23.8% | 2.1% | |
| LTM Aug 2026 | $89.34M USD | +2.7% | -8.0% | 1.4% | |
| LTM Sep 2026 | $58M USD | -4.9% | +32.9% | 1.4% | |
| LTM Aug 2026 | $16.7M USD | +10.6% | -32.1% | 0.5% | |
| LTM Jun 2026 | CN¥0 CNY | — | — | 0.0% | |
| Peer median (excluding DDS) | — | -4.3% | -10.9% | 3.2% | |
Competitors are the stored peer set for DDS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jan 2022 | FY2022 Jan 2023 | FY2023 Feb 2024 | FY2024 Feb 2025 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 862.47M | 891.64M | 738.85M | 593.48M | 570.2M |
| Depreciation & Amortization | 201.44M | 190.03M | 181.18M | 179.52M | 180.9M |
| Deferred Income Tax | (7.45M) | (15.3M) | (17.72M) | (8.99M) | (7.3M) |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 |
| Change in Working Capital | 242.52M | (93.56M) | (6.98M) | (37.65M) | 2.4M |
| Accounts Receivables | (3.08M) | (17.18M) | (3.6M) | 4.85M | 16M |
| Inventory | 7.59M | (40.03M) | 26.21M | (78.05M) | (29M) |
| Accounts Payables | 122.61M | (28.58M) | (22.49M) | 36.47M | (2.3M) |
| Other Working Capital | 115.41M | (7.78M) | (7.11M) | (917K) | 17.7M |
| Other Non-Cash Items | (18.96M) | (24.41M) | (11.73M) | (12.23M) | (29.2M) |
| Operating Cash Flow | 1.28B | 948.39M | 883.59M | 714.13M | 717M |
| Capital Expenditures | (104.36M) | (120.11M) | (132.94M) | (104.55M) | (93.4M) |
| Acquisitions (Net) | 0 | 0 | 0 | 703K | 0 |
| Purchases of Investments | 0 | (245.7M) | (295.35M) | (696.73M) | (534.6M) |
| Sales of Investments | 0 | 100M | 301.9M | 530.85M | 657.6M |
| Other Investing Activities | 34.57M | 29.95M | 10.81M | 0 | (7.1M) |
| Investing Cash Flow | (69.79M) | (235.85M) | (115.59M) | (269.73M) | 22.5M |
| Debt Repayment | (695K) | (44.8M) | 0 | 0 | 0 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (544.87M) | (452.85M) | (281.41M) | (121.03M) | (107.8M) |
| Dividends Paid | (305.24M) | (271.31M) | (338.63M) | (413.8M) | (484.8M) |
| Other Financing Activities | (3.01M) | 0 | 0 | 0 | (3.3M) |
| Financing Cash Flow | (853.81M) | (768.97M) | (620.04M) | (534.83M) | (595.9M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 356.42M | (56.43M) | 147.96M | (90.43M) | 143.6M |
| Free Cash Flow | 1.18B | 828.29M | 750.65M | 609.58M | 623.6M |
Dillard's, Inc.
NYSE:DDS
Intrinsic Alpha fair value
Locked
Current Price
$642.29
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.